JHS Svendgaard Completes Rs 3.75 Crore Preferential Allotment to Coeus Global Opportunities Fund

JHS Svendgaard Laboratories Limited ( (IN:JHS) ) has provided an announcement.

JHS Svendgaard Laboratories Limited has approved the conversion of 18,01,801 fully convertible warrants into an equal number of equity shares of face value Rs 10 each at an issue price of Rs 27.75 per share, following receipt of the remaining 75% of the warrant price aggregating to about Rs 3.75 crore from Coeus Global Opportunities Fund, a non-promoter group investor. This preferential allotment on a private placement basis increases the company’s paid-up equity share capital to Rs 87.41 crore, with the newly issued shares ranking pari passu with existing equity, effectively completing the warrant conversion program disclosed earlier and marginally diluting existing shareholders while strengthening the company’s equity base.

More about JHS Svendgaard Laboratories Limited

JHS Svendgaard Laboratories Limited operates in the oral care and personal care products space, providing manufacturing and related services, with its equity shares listed on both the Bombay Stock Exchange and the National Stock Exchange under the symbol JHS.

Average Trading Volume: 18,751

Technical Sentiment Signal: Sell

Current Market Cap: 896.3M INR

See more data about JHS stock on TipRanks’ Stock Analysis page.